CHTR vs FGEN · P/E 11, rev $13.53B vs rev $29.6M
Charter Communications Inc (CHTR) versus FibroGen Inc (FGEN) — a side-by-side from cached financials, not a winner call.
Charter Communications Inc (CHTR) is a telecom services company listed on US.
FibroGen Inc (FGEN) is a biotechnology company listed on NASDAQ.
Latest reported CHTR revenue for 2026-06-30 was $13.53B. Net income was $1.29B. Revenue was down 0.5% from 2026-03-31 to 2026-06-30. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
Latest reported FGEN revenue for 2024-12-31 was $29.6M. Net income was -$47.6M. Revenue was down 36.7% from 2023-12-31 to 2024-12-31. FGEN currently screens at market cap $39.3M.
CHTR currently screens at market cap $56.24B and trailing P/E 11.5. FGEN currently screens at market cap $39.3M.
Not investment advice. Open the CHTR and FGEN stock pages for the full models.
Not investment advice.